REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 170 filers reported holding REGENXBIO INC in Q1 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,972,314 | -39.3% | 339,514 | +9.3% | 0.00% | 0.0% |
| Q1 2024 | $6,545,775 | +8.0% | 310,668 | -8.0% | 0.00% | 0.0% |
| Q4 2023 | $6,063,026 | +2.1% | 337,773 | -6.4% | 0.00% | 0.0% |
| Q3 2023 | $5,937,058 | -19.1% | 360,696 | -1.7% | 0.00% | -50.0% |
| Q2 2023 | $7,335,490 | +9.3% | 366,958 | +3.4% | 0.00% | +100.0% |
| Q1 2023 | $6,710,837 | -17.6% | 354,883 | -1.1% | 0.00% | -50.0% |
| Q4 2022 | $8,141,145 | -9.4% | 358,957 | +5.6% | 0.00% | 0.0% |
| Q3 2022 | $8,988,000 | +8.5% | 340,056 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $8,284,000 | -27.6% | 335,361 | -2.7% | 0.00% | 0.0% |
| Q1 2022 | $11,440,000 | +1.8% | 344,671 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $11,241,000 | -20.9% | 343,750 | +1.4% | 0.00% | -33.3% |
| Q3 2021 | $14,206,000 | +14.3% | 338,873 | +5.9% | 0.00% | +50.0% |
| Q2 2021 | $12,432,000 | +4.4% | 320,004 | -8.3% | 0.00% | 0.0% |
| Q1 2021 | $11,910,000 | -16.6% | 349,133 | +10.9% | 0.00% | -33.3% |
| Q4 2020 | $14,276,000 | +60.6% | 314,731 | -2.5% | 0.00% | +50.0% |
| Q3 2020 | $8,887,000 | -30.7% | 322,916 | -7.3% | 0.00% | -33.3% |
| Q2 2020 | $12,829,000 | +13.4% | 348,359 | -0.3% | 0.00% | -25.0% |
| Q1 2020 | $11,311,000 | -21.3% | 349,338 | -0.4% | 0.00% | 0.0% |
| Q4 2019 | $14,365,000 | +0.4% | 350,616 | -12.8% | 0.00% | 0.0% |
| Q3 2019 | $14,309,000 | -49.4% | 401,937 | -27.0% | 0.00% | -50.0% |
| Q2 2019 | $28,265,000 | -26.5% | 550,225 | -18.0% | 0.01% | -27.3% |
| Q1 2019 | $38,456,000 | +72.7% | 670,995 | +26.4% | 0.01% | +57.1% |
| Q4 2018 | $22,272,000 | -17.9% | 530,908 | +47.7% | 0.01% | 0.0% |
| Q3 2018 | $27,136,000 | +18.4% | 359,415 | +12.6% | 0.01% | +16.7% |
| Q2 2018 | $22,911,000 | +478.3% | 319,330 | +140.6% | 0.01% | +500.0% |
| Q1 2018 | $3,962,000 | -12.9% | 132,735 | -3.0% | 0.00% | 0.0% |
| Q4 2017 | $4,551,000 | -0.3% | 136,870 | -1.2% | 0.00% | 0.0% |
| Q3 2017 | $4,564,000 | +30.4% | 138,518 | -21.9% | 0.00% | 0.0% |
| Q2 2017 | $3,501,000 | +23.8% | 177,277 | +21.0% | 0.00% | 0.0% |
| Q1 2017 | $2,828,000 | -1.1% | 146,552 | -4.9% | 0.00% | 0.0% |
| Q4 2016 | $2,859,000 | +263.7% | 154,145 | +174.8% | 0.00% | – |
| Q3 2016 | $786,000 | +124.6% | 56,091 | +28.2% | 0.00% | – |
| Q2 2016 | $350,000 | +68.3% | 43,740 | +126.0% | 0.00% | – |
| Q1 2016 | $208,000 | -31.4% | 19,352 | +5.9% | 0.00% | – |
| Q4 2015 | $303,000 | – | 18,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 743,079 | $14,854,149 | 9.91% |
| Aquilo Capital Management, LLC | 870,114 | $17,393,579 | 9.64% |
| MPM BioImpact LLC | 656,718 | $13,127,793 | 2.64% |
| ArchPoint Investors | 224,278 | $4,483,317 | 1.73% |
| Redmile Group, LLC | 2,026,576 | $40,511,254 | 1.56% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 35,396 | $707,566 | 1.36% |
| WS MANAGEMENT LLLP | 795,778 | $15,907,602 | 1.33% |
| Redwood Wealth Management Group, LLC | 14,760 | $295,052 | 0.33% |
| SummerHaven Investment Management, LLC | 21,298 | $425,747 | 0.27% |
| HARBOR CAPITAL ADVISORS, INC. | 44,106 | $881,679 | 0.18% |